Home » Topics » BioWorld Science

BioWorld Science
RSS

CIDRAP receives funding to create coronavirus vaccines R&D roadmap

April 27, 2022

PharmAbcine reports GLP toxicology results for TIE2-activating antibody PMC-403

April 27, 2022

Virpax reports preclinical PK results for VRP-324 for management of seizures

April 27, 2022

Algernon's NP-251 shown to reduce fibrosis in preclinical NASH study

April 27, 2022

NexImmune's AIM ACT to be studied in Columbia University's PDO models of HPV-associated cancers

April 27, 2022

ECCMID 2022: In antibiotic development, scientific ingenuity meets a dysfunctional marketplace

April 27, 2022

AstraZeneca presents new PROTACs for cancer

April 27, 2022

Cullgen identifies new PROTACs

April 27, 2022

Scorpion Therapeutics describes new EGFR and/or HER2 inhibitors

April 27, 2022

LYL-797, ROR1-targeted CAR T-cell candidate designed using reprogramming technologies

April 27, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...